Series X Preferred Stock Financing of Akebia Therapeutics

In July 2012, our lawyers represented Novartis Bioventures in the Series X Preferred Stock Financing of Akebia Therapeutics, Inc. Novartis Bioventures, is a venture fund based in Cambridge, Massachusetts. Akebia Therapeutics, Inc., based in Cincinnati, Ohio, is a biopharmaceutical company that engages in the discovery and development of small molecules for the treatment of anemia and vascular disorders. Akebia Therapeutics, Inc. was founded in 2007. Novartis Bioventures, is a venture fund based in Cambridge, Massachusetts.
Posted on July 9, 2012